In this work, our data suggested that LINC00022 is a novel downstream target of FTO, and FTO mimics the promoting effect of oncogenic LINC00022 on ESCC tumorigenesis. This evidence concerns the gene DLEU2 and esophageal squamous cell carcinoma.